Iridex Corp
IRIX- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001006045
In the last 90 days, Iridex Corp insiders filed 4 open-market purchases and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.47M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Iridex Corp changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 27 | 24 | −3 |
| Shares | 3.23M | 3.15M | −81.9K (−2.5%) |
| Value | $5.43M | $3.19M | −$2.24M (−41.3%) |
New holders (2)
Institutions that held Iridex Corp at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Concurrent Investment Advisors, LLC | 21,944 | $21.7K | 0.00% |
| XTX Topco Ltd | 10,311 | $10.2K | 0.00% |
Sold out (5)
Institutions that held Iridex Corp at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Bridgeway Capital Management, LLC | 70,000 | $117.6K |
| Long Focus Capital Management, LLC | 38,173 | $64.1K |
| Susquehanna International Group, LLP | 30,869 | $51.9K |
| Truist Financial Corp | 12,979 | $31.1K |
| Venturi Wealth Management, LLC | 750 | $1.26K |